Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
EAN 2022
ESOC 2022
AAN 2022
CONy 2022
AD/PD 2022
World Sleep 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Huntington’s Disease
4:24
Ongoing trials with importance for Huntington’s disease
Jee Bang
• 4 Apr 2022
2:26
Targets in DNA repair machinery for the treatment of Huntington’s disease
Jee Bang
• 4 Apr 2022
1:25
How can we develop better DMTs in Huntington’s disease?
Anne Rosser
• 23 Sep 2021
3:28
A multidisciplinary approach to providing care in Huntington’s disease
Anne Rosser
• 23 Sep 2021
2:20
Update: novel disease-modifying treatments in development for Huntington’s disease
Anne Rosser
• 23 Sep 2021
2:58
Phase I trial of fetal striatal cell transplantation in Huntington’s disease
Anne Rosser
• 23 Sep 2021
3:39
Verbal skills and neurodegeneration
Adolfo Garcia
• 20 Sep 2021
13:42
RNA- and DNA- based therapies for neurodegenerative & neuromuscular diseases
Aida Abu-Baker
• 11 Oct 2021
3:23
Gene-based therapies for neurodegenerative & neuromuscular diseases
Aida Abu-Baker
• 11 Oct 2021
8:36
Triheptanoin: targeting the Krebs cycle in Huntington’s disease
Fanny Mochel
• 24 Sep 2021
2:45
Manipulating protein quality control systems in neurodegenerative diseases: next steps
Anne Bertolotti
• 30 Jul 2021
3:58
Increasing eIF2a phosphorylation to boost protein quality control in neurodegenerative disease
Anne Bertolotti
• 30 Jul 2021
6:14
Protecting cells from misfolding stress to improve cell survival in neurodegenerative disease
Anne Bertolotti
• 30 Jul 2021
4:21
Emerging concepts: boosting protein quality control to treat neurodegenerative disease
Anne Bertolotti
• 30 Jul 2021
1:54
Therapies in the pipeline for Huntington’s disease
Anne Rosser
• 18 Jun 2021
2:58
Cell therapy in Huntington’s disease: where are we now?
Anne Rosser
• 18 Jun 2021
1
2
3
Next